Description
The standardized extract of Bacopa monnieri (Brahmi), the South Asian creeping herb central to Ayurvedic medicine for cognitive function and memory. Standardized to bacoside content, the principal triterpene saponin active fraction. Used in nootropic, memory-support, and stress-management dietary supplements globally.
Yellow-brown to brown free-flowing powder. Limited water solubility; freely soluble in alcohol.
We supply food-grade Bacopa Monnieri Extract from manufacturers in China holding ISO, Halal, Kosher and other certifications relevant to the product and production.
Common market grades include 20 percent Bacosides (cost-effective baseline), 25 percent Bacosides (standard supplement grade), 50 percent Bacosides (the premium grade matching the CDRI-08 clinical reference specification), and Bacognize Brand-Equivalent (premium positioned at 12 percent bacopa glycosides by validated HPLC method).
Bulk and reduced-MOQ shipments. Batch-level COA covering total bacosides (UV), bacopaside I and bacoside A3 (HPLC), residual solvents, heavy metals, pesticides, and microbiology.
Introduction
Bacopa monnieri (Brahmi, the herb of wisdom) has been used in Ayurvedic medicine for over 3,000 years for memory, learning, and meditation support. The plant grows in wetlands and marshy areas across South Asia, where it has been incorporated into traditional rasayana longevity formulations.
Industrial production proceeds by hot-water and ethanol extraction of dried Bacopa aerial parts, followed by purification and standardization to defined bacoside content. Premium grades match the CDRI-08 specification developed by the Central Drug Research Institute of India, the most clinically-studied Bacopa preparation.
Recognized as a permitted food ingredient by the U.S. FDA, the European Food Safety Authority, and equivalent regulators worldwide.
The bacoside triterpene saponins have well-documented effects on acetylcholine and serotonin neurotransmission in animal models. Clinical evidence supports modest cognitive improvement at appropriate doses (typically 300 mg of 50 percent bacoside extract per day for 12 weeks or longer), with effects typically requiring sustained supplementation rather than acute single doses.
Strategic positioning is dominated by the nootropic and memory-support supplement segments, where Bacopa serves as a premium-positioning natural alternative to caffeine and synthetic nootropics with substantial clinical evidence support.
Where it is used
- Nootropic and cognitive-function dietary supplements: memory, focus, and learning-positioned formulations (the dominant commercial application)
- Stress-management and adaptogen-positioned supplement formulations
- Premium senior-positioned brain-health supplement formulations
- Children's cognitive-support supplements (a growing segment in some markets)
- Traditional Ayurvedic medicine: brahmi rasayana and modern granule formats
- Anxiety-management and calming-positioned supplements
- Functional beverages: nootropic drinks and adaptogenic blends
- Pharmaceutical research applications including cognitive-decline clinical trials
Technical data
| Item | Specification |
|---|---|
| Appearance | Yellow-brown to brown free-flowing powder |
| Total bacosides (UV) | 20% / 25% / 50% (grade dependent) |
| Bacopaside I plus Bacoside A3 (HPLC) | ≥ 12% (premium HPLC-method grade) |
| Loss on drying | ≤ 5.0% |
| Residue on ignition | ≤ 5.0% |
| Heavy metals (as Pb) | ≤ 2 mg/kg |
| Total plate count | ≤ 10000 cfu/g |
| Source | Bacopa monnieri dried aerial parts |
Ready to discuss business?
Send us your spec and requirement. We will respond with availability and pricing within 24 hours.